{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:35:54Z","timestamp":1791272154287,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001342","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T21:40:50Z","timestamp":1318369250000},"page":"e1342","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":104,"title":["Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever"],"prefix":"10.1371","volume":"5","author":[{"given":"Michelle","family":"Mendenhall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald F.","family":"Smee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery O.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Skirpstunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian B.","family":"Gowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0166-3542(02)00202-4","article-title":"Arenaviruses other than Lassa virus.","volume":"57","author":"RN Charrel","year":"2003","journal-title":"Antiviral Research"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1000047","DOI":"10.1371\/journal.ppat.1000047","article-title":"Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia.","volume":"4","author":"S Delgado","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e1000455","DOI":"10.1371\/journal.ppat.1000455","article-title":"Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa.","volume":"5","author":"T Briese","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1371\/journal.pntd.0000388","article-title":"Risk maps of Lassa fever in West Africa.","volume":"3","author":"E Fichet-Calvet","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","article-title":"Treatment of Argentine hemorrhagic fever.","volume":"78","author":"DA Enria","year":"2008","journal-title":"Antiviral Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(79)92335-3","article-title":"Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome.","volume":"2","author":"JI Maiztegui","year":"1979","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0166-3542(87)90017-9","article-title":"Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever.","volume":"7","author":"DA Enria","year":"1987","journal-title":"Antiviral Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/clind\/24.4.718","article-title":"Treatment of Bolivian hemorrhagic fever with intravenous ribavirin.","volume":"24","author":"PE Kilgore","year":"1997","journal-title":"Clinical Infectious Diseases"},{"key":"ref9","first-page":"20","article-title":"Lassa fever. Effective therapy with ribavirin.","volume":"314","author":"JB McCormick","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management.","volume":"287","author":"L Borio","year":"2002","journal-title":"Jama"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.510260231","article-title":"Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.","volume":"26","author":"HC Bodenheimer Jr","year":"1997","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/135965359900400404","article-title":"Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group.","volume":"4","author":"LE Chapman","year":"1999","journal-title":"Antivir Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0166-3542(92)90073-E","article-title":"Unexpected adverse reactions during a clinical trial in rural west Africa.","volume":"19","author":"SP Fisher-Hoch","year":"1992","journal-title":"Antiviral Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2174\/092986706778773059","article-title":"Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research.","volume":"13","author":"S Russmann","year":"2006","journal-title":"Curr Med Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0041-008X(80)90252-5","article-title":"Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice.","volume":"52","author":"DM Kochhar","year":"1980","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/tera.1420170117","article-title":"Teratogenic effects of ribavirin on hamster and rat embryos.","volume":"17","author":"VH Ferm","year":"1978","journal-title":"Teratology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/657315","article-title":"Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.","volume":"51","author":"DG Bausch","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705.","volume":"46","author":"Y Furuta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections.","volume":"51","author":"BB Gowen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.antiviral.2008.07.009","article-title":"Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents.","volume":"80","author":"JD Morrey","year":"2008","journal-title":"Antiviral research"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AAC.01074-08","article-title":"Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106.","volume":"53","author":"JG Julander","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0909603107","article-title":"T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.","volume":"107","author":"M Kiso","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","article-title":"In Vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.","volume":"54","author":"K Sleeman","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e3725","DOI":"10.1371\/journal.pone.0003725","article-title":"Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.","volume":"3","author":"BB Gowen","year":"2008","journal-title":"PLoS One"},{"key":"ref25","article-title":"T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture.","author":"M Mendenhall","year":"2010"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e1000836","DOI":"10.1371\/journal.ppat.1000836","article-title":"T cell-dependence of Lassa fever pathogenesis.","volume":"6","author":"L Flatz","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref27","article-title":"Mice lacking interferon {alpha}\/{beta} and {gamma} receptors are susceptible to Junin virus infection.","author":"OA Kolokoltsova","year":"2010","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/IAI.37.2.771-778.1982","article-title":"Pathogenesis of Lassa virus infection in guinea pigs.","volume":"37","author":"PB Jahrling","year":"1982","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.4269\/ajtmh.1984.33.1251","article-title":"The guinea pig model for Argentine hemorrhagic fever.","volume":"33","author":"JR Oubina","year":"1984","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4269\/ajtmh.2008.79.275","article-title":"Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs.","volume":"79","author":"NE Yun","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4269\/ajtmh.1996.55.81","article-title":"Experimental infection of guinea pigs with Venezuelan hemorrhagic fever virus (Guanarito): a model of human disease.","volume":"55","author":"WC Hall","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/IAI.32.2.872-880.1981","article-title":"Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs.","volume":"32","author":"PB Jahrling","year":"1981","journal-title":"Infection and Immunity"},{"key":"ref33","first-page":"228","article-title":"Pathological and virological features of arenavirus disease in guinea pigs. Comparison of two Pichinde virus strains.","volume":"145","author":"JF Aronson","year":"1994","journal-title":"American Journal of Pathology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0166-3542(94)90030-2","article-title":"Antiviral treatment of Argentine hemorrhagic fever.","volume":"23","author":"DA Enria","year":"1994","journal-title":"Antiviral Research"},{"key":"ref35","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints.","volume":"27","author":"LJ Reed","year":"1938","journal-title":"American Journal of Hygiene"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4269\/ajtmh.1999.61.220","article-title":"Sequence analysis of the small RNA segment of guinea pig-passaged Pichinde virus variants.","volume":"61","author":"L Zhang","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/viro.2001.1127","article-title":"Reassortant analysis of guinea pig virulence of pichinde virus variants.","volume":"290","author":"L Zhang","year":"2001","journal-title":"Virology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1099\/vir.0.2008\/002048-0","article-title":"Cytokine patterns in a comparative model of arenavirus haemorrhagic fever in guinea pigs.","volume":"89","author":"EP Scott","year":"2008","journal-title":"J Gen Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1128\/JVI.00019-09","article-title":"Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers.","volume":"83","author":"S Lan","year":"2009","journal-title":"J Virol"},{"key":"ref40","first-page":"28","article-title":"Platelet distribution width: a simple, practical and specific marker of activation of coagulation.","volume":"14","author":"E Vagdatli","year":"2010","journal-title":"Hippokratia"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.jacc.2007.02.038","article-title":"Platelet surface CD62P and CD63, mean platelet volume, and soluble\/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of \u201chealthy control subjects\u201d and \u201cdisease control subjects\u201d in sinus rhythm.","volume":"49","author":"A Choudhury","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges.","volume":"10","author":"TW Geisbert","year":"2004","journal-title":"Nat Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1160\/TH09-06-0357","article-title":"The role of the vascular endothelium in arenavirus haemorrhagic fevers.","volume":"102","author":"S Kunz","year":"2009","journal-title":"Thromb Haemost"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4269\/ajtmh.1993.49.10","article-title":"Pathogenesis of Pichinde virus infection in strain 13 guinea pigs: an immunocytochemical, virologic, and clinical chemistry study.","volume":"49","author":"BM Connolly","year":"1993","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"ref45","first-page":"349","article-title":"Pathologic and virologic study of fatal Lassa fever in man.","volume":"107","author":"DH Walker","year":"1982","journal-title":"American Journal of Pathology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2009.10.015","article-title":"Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models.","volume":"86","author":"BB Gowen","year":"2010","journal-title":"Antiviral Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2007.10.002","article-title":"Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses.","volume":"78","author":"BB Gowen","year":"2008","journal-title":"Antiviral Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0166-3542(89)90055-7","article-title":"Arenavirus infection in the guinea pig model: antiviral therapy with recombinant interferon-alpha, the immunomodulator CL246,738 and ribavirin.","volume":"12","author":"HL Lucia","year":"1989","journal-title":"Antiviral Research"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nm.1885","article-title":"Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases.","volume":"14","author":"MM Soares","year":"2008","journal-title":"Nat Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1743-422X-7-240","article-title":"Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever.","volume":"7","author":"BB Gowen","year":"2010","journal-title":"Virol J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/155.3.456","article-title":"Clinical virology of Lassa fever in hospitalized patients.","volume":"155","author":"KM Johnson","year":"1987","journal-title":"J Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited.","volume":"22","author":"S Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus.","volume":"49","author":"Y Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T11:47:28Z","timestamp":1686397648000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001342"}},"subtitle":[],"editor":[{"given":"Daniel G.","family":"Bausch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001342","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]}}}